These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 11829825)
1. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts]. Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825 [TBL] [Abstract][Full Text] [Related]
2. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt]. Zhang Z; Feng H; Leng X; Ma F; Wang B; Du R Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864 [TBL] [Abstract][Full Text] [Related]
3. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon. Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812 [TBL] [Abstract][Full Text] [Related]
4. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication]. Yin J; Leng X; Zhu J Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881 [TBL] [Abstract][Full Text] [Related]
5. Immediate changes in blood flow and oxygen metabolism of the cirrhotic liver following portacaval shunt operations. Delin NA; Ekeström S; Lindahl J; Nylander G; Sundblad R Surg Gynecol Obstet; 1977 Apr; 144(4):499-503. PubMed ID: 847602 [TBL] [Abstract][Full Text] [Related]
6. [Perioperative plasma amino acid spectrum analysis in portal hypertensive cirrhotic patients undergoing portacaval H-graft shunt]. Zhu J; Liu F; Leng X Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):299-301. PubMed ID: 10374569 [TBL] [Abstract][Full Text] [Related]
7. Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients. Praticò D; Rossi E; Merli M; Riggio O; FitzGerald GA; Violi F J Investig Med; 1998 Dec; 46(9):430-4. PubMed ID: 9861778 [TBL] [Abstract][Full Text] [Related]
8. Glucagon and insulin metabolism in cirrhotic patients. Yoshida T; Ninomiya K; Matsumoto T; Baatar D; Bandoh T; Kitano S Hepatogastroenterology; 1998; 45(20):468-71. PubMed ID: 9638429 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary experimental study on treatment of portal hypertension with auxiliary partial orthotopic liver transplantation]. Shi LB; Peng CH; Peng SY; Liu YB; He W; Xu B; Chen XP; Bai MD; Wang Y; Tang Z Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):730-3. PubMed ID: 15585146 [TBL] [Abstract][Full Text] [Related]
10. Hyperglucagonemia and hyperdynamic circulation in rats with biliary cirrhosis. Ohara N; Jaspan J; Chang SW J Lab Clin Med; 1993 Jan; 121(1):142-7. PubMed ID: 8426077 [TBL] [Abstract][Full Text] [Related]
11. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study. Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248 [TBL] [Abstract][Full Text] [Related]
12. Small-diameter prosthetic H-graft portacaval shunts in the treatment of portal hypertension. Hu HJ; Xu GL; Li JS; Yang SG; Chai ZP; Xu RN Chin Med J (Engl); 2004 Feb; 117(2):195-8. PubMed ID: 14975201 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation. Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of epinephrine and norepinephrine in cirrhotic patients with portal hypertension. Zhu J; Leng X; Zhao H; Chen L; Du R Chin Med J (Engl); 1998 Jun; 111(6):504-6. PubMed ID: 11245067 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the blood flow of superior portacaval anastomoses by the measurement of azygos blood flow in patients with alcoholic cirrhosis]. Braillon A; Calès P; Jirón MI; Lebrec D Gastroenterol Clin Biol; 1984 Jan; 8(1):47-51. PubMed ID: 6698342 [TBL] [Abstract][Full Text] [Related]
16. Effects of combined splenorenal shunt devascularization and devascularization only on hemodynamics of the portal venous system in patients with portal hypertension. Cao H; Hua R; Wu ZY Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):385-8. PubMed ID: 16109521 [TBL] [Abstract][Full Text] [Related]
17. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis. Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090 [TBL] [Abstract][Full Text] [Related]
18. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension. Zhang ZT; Jiang P; Wang Y; Li JS; Xue JG; Zhou YZ; Yuan Z Chin Med J (Engl); 2006 Oct; 119(20):1727-33. PubMed ID: 17097021 [TBL] [Abstract][Full Text] [Related]
19. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension]. Li S; Feng H; Zhu J; Zhong C; Leng X; Du R Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169 [TBL] [Abstract][Full Text] [Related]
20. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis. Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]